This Is MS

An independent community for those affected by Multiple Sclerosis featuring the latest news and research



You are currently viewing the Site Map index page.
We suggest you look at the original content.




This Is MS » Latest 200 News Articles:

  • Oral Therapy Laquinimod to Start Phase III Trials for RRMS

  • MS Walking Improvement Drug Gets FDA Help

  • Daclizumab Shows Promise in Phase II Trial for Relapsing Remitting MS

  • Minimal Changes in Cognitive Function of Relapsing-Remitting MS'ers in a 10-year

  • PML Seen with Rituxan for Lupus

  • Vitamin D Reduces Risk of Multiple Sclerosis

  • Opexa Begins Phase IIb Study on Tovaxin

  • Oral Therapy FTY720 (Fingolimod) Shows Promise for MS

  • Rituxan Has Positive Phase II Results

  • Teva to Examine Neutralizing Antibodies to Interferon

  • Fathers More Likely to Pass MS to Children

  • And Then There Were Six (Again)

  • MS and Diabetes Linked

  • Tysabri Approved For Return in Europe

  • Tysabri Price Rises Nearly Twenty Percent

  • Tysabri Cleared to Return to Market

  • Hope and Heartbreak: The Path of Tysabri as a Treatment for Multiple Sclerosis

  • Biogen Buys Another Promising MS Drug (BG-12)

  • Early Treatment Favoured for MS

  • Elan Says Tysabri on Track, Considers Price Hike

  • Monthly IV Steroids Could Prevent Relapses

  • Possible Method of Action for Copaxone Discovered

  • Keppra (Levetiracetam) shows Promise Against Tremor

  • First Formal Low Dose Naltrexone Study Results to be Presented

  • Possible Shift in Thinking about how Multiple Sclerosis Develops

  • BioMS expands MBP8298 trial to RRMS patients

  • Daclizumab Method of Action Surprises Researchers

  • FDA Extends Tysabri Review by up to 90 Days

  • US FDA PANEL UNANIMOUS: TYSABRI SHOULD RETURN

  • First Day of Tysabri AC Meeting Over

  • In Progress: Tysabri FDA Advisory Panel Review Meeting

  • New Tysabri Results Published in New England Journal of Medicine

  • Interesting new Research Abstracts on Tsyabri (Natalizumab)

  • Tysabri Cleared for Clinical Trial Use

  • MN-166 Enters Phase II trials in US

  • Tysabri to Receive FDA Verdict by end of March

  • FDA grants Priority Review to Tysabri Supplemental Application

  • Component of Turkey (Tryptophan) Promising in MS

  • Tysabri Crohn's and RA Safety Review Complete; No New PML

  • Novartis Oral Therapy FTY-720 Shows Phase II Success

  • Tysabri Supplemental Application Submitted to FDA

  • Elan and Biogen Plan Re-Launch of Tysabri

  • Stem Cells Repair Cord Damage; Produce Myelin

  • Campath Trials Temporarily Halted; Shows Promise

  • Long-Term Antibiotic Use Raises Cold and Flu Risk

  • Oral Contraceptives (Estrogen) Cut MS Risk

  • Study on Chlamydia Pneumonia Infection in Multiple Sclerosis Patients

  • Familial Risk of Multiple Sclerosis

  • Alpha-4 Integrin Inhibitors (e.g., Tysabri) May Sponsor Remyelination

  • Vitamin D shows Promise in Treating RRMS

  • Birth Order has no Effect on MS Risk

  • Tysabri MS Patients Screened: No new PML cases

  • Biogen Purchases Rights to Daclizumab From PDL

  • Lessons from Campath: Early Protection of CNS Critical

  • Biogen Provides Update on Status of Tysabri

  • Minocycline Downregulates T-Cell Activity

  • PRISMS Crossover Study Corroborates Benefit of Rebif as Treatment for RRMS

  • Biogen, Elan sued over Tysabri PML Death

  • Restless Leg Syndrome More Common in MS'ers

  • Stem cells may automatically protect brain

  • Aimspro Update -- It is still Alive

  • Theory: Tysabri PML link may be due to Overdosing

  • Emotional Incontinence Drug Submitted for Final Approval

  • Tysabri Posts Positive Crohn's Data; Safety Review ''on-track''

  • Rumors of a 5th Tysabri PML Case... And Thoughts on the "Cases" yet to Come

  • Doubt Cast on 4th PML Case

  • New England Journal of Medicine Reviews Tysabri PML Cases

  • Complete FDA Biologics Application for Tysabri

  • More Details on the Suspected 4th Tysabri PML Case

  • Reports of a 4th Tysabri-PML Case

  • Tysabri: Not IF but WHEN

  • New Article: The JC Virus Story in MS (PML-Tysabri related)

  • Biogen Discovers Myelin-Production Protein

  • A Case of Recovery from PML

  • Viagra (sildenafil citrate) Useful for Men with MS

  • Supplement N-acetyl-L-cysteine (NAC) shown beneficial in EAE

  • Acorda Gets FDA Assistance for Phase III Trial of Fampridine-SR

  • Possible Mode of Action for Statins in MS

  • Possible Tysabri Comeback Scenario

  • Tysabri Safety Review to be Completed by Late Summer

  • Provigil Ineffective for MS Fatigue; Aspirin Might Help

  • Contacting the FDA About Tysabri

  • Sativex (Marijuana Spray for MS) Approved in Canada

  • Tysabri 2 Year Results Out: Strong Efficacy and Reduction of Disease Progression

  • Daval Explains why Aimspro Trial Halted

  • Revealing Medical History of 3rd Tysabri Patient with PML

  • 3rd Case of PML found for Tysabri

  • Laquinimod (oral therapy) Successful in Phase II Trial

  • Aimspro Successful in Optic Neuritis Trials

  • Smoking Raises Risk of MS Conversion to Secondary Progressive

  • FDA: Avonex can cause Severe Liver Injury

  • More Fallout: Glaxo Halts MS Drug Trial on Tysabri Recall

  • US Army to take Brain Injury Drug to Trials

  • Antisense Halts Phase II Trial for Tysabri-like ATL1102

  • 2nd Patient on Tysabri/Avonex Combo Confirmed with PML

  • Daval Halts Aimspro Trial over ''Hospital Protocol Concerns''

  • New Phase II NeuroVax Study for MS

  • Tysabri could be ''back on the market by Fall''

  • Tysabri Voluntarily Suspended

  • New Study: Combination of Copaxone and Anti-Oxidant NAC

  • Tysabri 2 year Data Out: Significant Reduction in Disability and Relapses

  • Elan's Investor Conference Call Notes Regarding Tysabri

  • Statins Beneficial for Spinal Cord Injury (in rats)

  • Link to Biogen Investor Call February 7th, 2005

  • Tysabri Online Educational Seminar by the Cleveland Clinic

  • Novartis' Oral MS Therapy FTY720 Successful in Phase II Trials

  • Sex Hormones Modulate Brain Injury in Multiple Sclerosis

  • Tysabri Mode of Action Video

  • Tysabri a Hit at Major Healthcare Conference

  • Let the wars begin: Rebif versus Tysabri

  • Study Shows Weight Training Gives MS Patients Physical, Emotional Benefits

  • Phase III Trial of Oral MS Therapy Mylinax (Cladribine) Initiated

  • National Multiple Sclerosis Society's 2004 MS Summary

  • Tysabri Product Information

  • Reactions to Tysabri Approval (also known as Antegren or Natalizumab)

  • Antegren (Tysabri) Receives FDA approval for Treatment of Relapsing Remitting MS

  • Tysabri!?! Antegren to be renamed...

  • GlaxoSmithKline Updates on new Oral MS Therapy 683699

  • Alzheimer's Drug Aricept Helps Memory in Multiple Sclerosis

  • Antegren One-Year Data Out: 66% Reduction in Relapses

  • Non-Antibacterial Tetracylines Protective in Animal MS Models

  • Rebif Market Share Growing; Antegren Viewed as Biggest Threat

  • Coffee Linked to Inflammation

  • IV Immunoglobulin After First MS Event Is A Preventative

  • After 10 years, 91% of Copaxone Users Still Walk Unaided

  • MS Patients More Sensitive to Gluten

  • Teaching MS Patients to Save Energy Curbs Fatigue

  • Long Term Study of Rebif Shows Positive Results

  • Component of a Virus (Synctin) Linked to Multiple Sclerosis

  • Bacterial Infection Linked to Crohn's Disease (Is Bacteria the Cause of MS?)

  • Research Theorizes why Myelin Breakdown Occurs in MS

  • Talk with Teva and Active Biotech about Laquinimod (Oral Therapy for MS)

  • Hepatitis B Vaccine Linked with Higher Incidence of Multiple Sclerosis

  • Researcher: Stem Cell Treatment for MS ''likely soon''

  • Carbon Monoxide Poisoning Induces Similar Changes to Myelin as seen in MS

  • MS'ers with Few Symptoms Over Time Likely to Stay Well; Do Not Require Treatment

  • Pregnancy best treatment for MS; Estrogen is key

  • Stem Cells Eliminate Rheumatoid Arthritis in Patient

  • Excessive Emotions Drug Neurodex Successful in Phase III Trial

  • Ibuprofen Best for Treating Post-Avonex-Injection Side Effects

  • Chiropractic Correction of Neck Injuries may Halt MS Progression

  • Antegren to go for approval in Canada, Switzerland and Australia on 1 Year Data

  • Goat Serum (Aimspro) Update -- new MS trial in October

  • Warning: Do Not Purchase ''Goat Serum'' over the Internet

  • Copaxone Better at Relieving Fatigue than Interferons

  • An Update on Vitamin D and MS

  • Interferon-Beta Treatment Improves Blood-Brain Barrier

  • Study on "Benign" Multiple Sclerosis

  • Teva updates on Copaxone and Laquinimod (oral MS therapy)

  • Cannabis Relieves Multiple Sclerosis Pain

  • Interferon Therapy Takes Months to Reach Therapeutic Effect

  • Interferon 3 Times Weekly More Effective than Once per week

  • Mood Dysfunction not Related to MS Progression

  • Differences in Cognitive Impairment by Type of MS

  • Aimspro (Goat Serum) Update

  • Elan Provides Antegren Update

  • FDA Accepts Biologics License Application for Antegren for Multiple Sclerosis

  • MS Deterioriation Reversed with Antibodies & Neuroprotectors (Glypromate / NBQX)

  • Infectious Agents Eyed as Culprit in Chronic Disease

  • Stress Temporarily Increases Immune Response

  • Antegren Approved for Expedited Review

  • Copaxone Every Other Day

  • Desipramine (anti-depressant) as a Treatment for Multiple Sclerosis

  • Teva to support Oral MS Therapy Research (Laquinimod)

  • Copaxone Pre-filled Now Available in Europe

  • Statins useful against Rheumatoid Arthritis

  • New Drug (LGD5552) Prevents EAE in Animals

  • How Much for the Hope

  • Stem Cells Isolated from Fetuses with Serious Diseases

  • Yoga Helps Treat MS Fatigue

  • Oral Diabetes Drug (Pioglitazone) to be tested for use in MS

  • A Key Difference between Avonex and Betaseron Treatment

  • Thoughts on Remyelination Strategies

  • Taking on MS: A War on Multiple Fronts

  • Minocycline (oral antibiotic) shows Promise for MS

  • Antegren Submitted to FDA Based on One-Year Trial Data

  • Daclizumab (human antibody) therapy improves MS outcome

  • Deep Brain Stimulation for Treating Tremor

  • This is MS Responds to NMSS Article on LDN

  • NMSS comes out against Low Dose Naltrexone for MS

  • Statins Show Promise in People with MS

  • IGIV for the Treatment of Multiple Sclerosis

  • Weekly Rebif Injections Not Useful in Secondary Progressive MS

  • Statins as Potential Therapeutic Agents in Multiple Sclerosis

  • Copaxone Possibly Effective for Primary Progressive MS

  • 10 Year Copaxone Study Shows it is Remarkably Effective

  • The Relationship of Sleep Disturbances and Fatigue in Multiple Sclerosis.

  • A Comparison of the Available MS Therapies

  • Copaxone Effective for Multiple Sclerosis

  • Remyelinating and Neuroprotective Treatments in Multiple Sclerosis

  • Campath for Multiple Sclerosis Completes Phase III Enrollment

  • Turmeric Fights Cystic Fibrosis

  • Fibrin Depletion Decreases Multiple Sclerosis Symptoms

  • Research on Viral Triggers in Children with MS

  • Role of Epstein-Barr (Mono) Virus and MS

  • Marijuana does not help Tremor

  • Interferon Beta 1b (Betaseron) Might Work by Plugging the Blood-Brain Barrier

  • 17-beta estradiol Protects Oligodendrocytes

  • Antegren Reduces Severity of New Lesions (in other words, Antegren Works)

  • Is it a Boomerang, or what? Controversial Thoughts on MS Research


    • This Is MS » Public Forums:

  • Accountabili-Body: Post your exercise and weight goals here, and the community will hold you accountable!

  • Aimspro: A forum to discuss Aimspro (Goat Serum) as a possible therapy for MS

  • Antibiotics: A forum for the discussion of antibiotics as a potential therapy for MS

  • Avonex: A board to discuss the Multiple Sclerosis modifying drug Avonex

  • Betaseron: A board to discuss the Multiple Sclerosis modifying drug Betaseron

  • Campath: A board to discuss the soon-to-be released drug Campath as a treatment for Multiple Sclerosis

  • Chronic Cerebrospinal Venous Insufficiency (CCSVI): A forum to discuss Chronic Cerebrospinal Venous Insufficiency and its possible relationship to Multiple Sclerosis.

  • Copaxone: A board to discuss the Multiple Sclerosis modifying drug Copaxone

  • Daily Life: A forum to talk about the general challenges of daily life with MS.

  • Diet: A board to discuss various diet-centered approaches to treating or controlling Multiple Sclerosis, e.g., the Swank Diet

  • Drug Pipeline: A board to discuss future MS therapies in early stage (Phase I or II) trials.

  • Friends and Family: For questions on how to support loved ones with MS.

  • Gene Therapy: Discuss topics relevant to gene therapy for MS here

  • General Discussion: If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

  • Humor: A board where people can laugh about their day to day experiences with MS, to combat some of the stress that goes with this illness.

  • Introductions: New members should feel free to introduce themselves here

  • Low Dose Naltrexone: A board to discuss Low Dose Naltrexone (LDN) as a treatment for Multiple Sclerosis

  • Medical Devices: Discuss physical medical devices that can be used to treat or improve MS symptoms

  • Mental & Spiritual Health: Discuss therapy (group & individual), pet therapy, faith, spirituality, and so on here.

  • MS in the Golden Years: A forum for discussing the unique concerns of senior members of the Multiple Sclerosis "Club."

  • Natural Approach: Discuss herbal therapies, vitamins and minerals, bee stings, etc. here

  • Novantrone: A board to discuss the Multiple Sclerosis modifying drug Novantrone

  • Parenting Kids With MS: This forum is for parents and caregivers of kids under 21 with MS.

  • Reading Nook: Discuss your favorite books here

  • Rebif: A board to discuss the Multiple Sclerosis modifying drug Rebif

  • Regimens: Tell us what you are using to treat your MS-- and how you are doing.

  • Revimmune (cyclophosphamide or cytoxan): A board to discuss Revimmune as a potential therapy for multiple sclerosis

  • Rituxan (Rituximab): A board to discuss the anticipated multiple sclerosis treatment Rituxan.

  • Shopping: Post internet shopping deals here, particularly for products useful for MS'ers. NO spamming allowed.

  • Site Support: If you're having any problems with the site, please post here and a site administrator will respond.

  • Statins: Discussion of statins (Lipitor, Zocor, etc.) in the treatment of MS.

  • Stem Cells: Discuss stem cells, adult and embryonic, and their therapeutic potential for MS here.

  • Suggestions: Ideas for things you'd like to see?

  • Tovaxin: A board to discuss Tovaxin as a treatment for Multiple Sclerosis

  • Tysabri (Antegren or Natalizumab): A board to discuss the newly-released drug Tysabri, (formerly known as Antegren) as a treatment for Multiple Sclerosis

  • Under 25 with MS: A forum dedicated to the younger people living with MS reflecting their unique concerns.


    • This Is MS » Latest 200 Public Topics:

  • Frequent Flyer Miles

  • Those who had L.treatment, how much did you mobility improve

  • My second trip to Poland

  • Dake Presentation at SIR Annual Scientific Meeting

  • Full account of my liberation posted on Wheelchair Kamikaze

  • Add-On Daclizumab Treatment May Be Better In Reducing MS

  • response to MS-Direct article

  • My CCSVI Diagnosis and (hopeful) Treatment

  • rebif 22mcg - how much in australia?

  • Hello, new here (Wanted opinions from actual MS sufferers.)

  • Anyone have MRI post-CCSVI tx or objective improvement?

  • CCSVI in Amman, Jordan

  • Mark Kalina, M.D.

  • UBC MS Clinic Appt...

  • MS Canada announces live web streaming event--CCSVI--

  • why not just treat fatigue for now?

  • Parkinson and MS cured by surgery (but not CCSVI)

  • going to poland March 23/24

  • My doctor's thoughts on vitamin D

  • fungal toxins

  • What should I ask my new neurologist?

  • Venn Diagrams

  • Worsening of symptoms

  • Will L.Treat benefit me when LDN has stopped my progression?

  • Improving Cognitive Function?

  • How safe is Ballooning?

  • Straining?

  • Jugular venoplasty video

  • CCSVI fundraising

  • Are Balloons safer than having stents?

  • CCSVI - STEP #1 and beyond

  • Donors have the power to get MS research underway

  • CCSVI Web Streaming Event

  • Minocycline use for RRMS

  • When to start Rebif?

  • Tracking Project - Where are those who underwent liberation

  • Cloning Dangers

  • lumbar/ spinal for diagnosis?

  • Stents for veins time to educate ourselves

  • Message from WH

  • Where can i have the liberation treatment? I live in the UK.

  • Standardized cannabis in Multiple Sclerosis: A case report

  • Back home, safe and sound.

  • CCSVI web streaming April 7, 2010

  • NMSS CCSVI research funding - panel members

  • Does anyone feel their MS has got worse?

  • Venogram done... no stenosis

  • ccsvi

  • The vascular group

  • Can ABX make you worse? Lyme or MS?

  • How Do They Test For CCSVI-I'm A Newbie

  • Newly Diagnosed

  • interventional radiology societies around the world

  • Fatigue, CCSVI and MS

  • neuro comments

  • argh!

  • prefilled injections

  • Ocrelizumab

  • What happens after CCSVI treatment?

  • Valve Regeneration as a Vein Angioplasty ISSUE

  • Switching from Copaxone to Avonex

  • Positive media results...Canadian content...

  • Feedback on sensitivity to herbs/drugs neuro MS explosions..

  • Testing for CCSVI in Boston?

  • Thank you

  • Do the neuros ignore CCSVI aspect of MS, this year?

  • Vote No 1 on the charts

  • Peptimmune announces second grant of a United States patent

  • Transferring money..

  • Inability to concentrate and focus

  • I'm new; just found out about this site...

  • Hi from Oz

  • Looking information about ameds.pl

  • FALSE CREEK not seeing AMERICANS?

  • Bathtubs

  • why not bypass surgery?

  • Ameds - new clinic in Poland

  • New update on husband/ waste of time

  • Self-selecting bias for CCSVI

  • Angiogram and Venogram scheduled!

  • CCSVI conference in Poland, March 12, 2010

  • Interesting info...

  • CCSVI

  • Post Liberation-Improve-physio

  • Announcement- CCSVI Alliance

  • interesting non-MS article

  • A long shot but...

  • Hi from London

  • Canadians Write a letter to a politician about CCSVI today!

  • Test Done

  • Buffalo is in business !!

  • tested in ireland

  • MSRC comments on Stanford University halting CCSVI treatment

  • Missing My Dad. MS sufferer for 20 years

  • Vitamin D 'triggers and arms' the immune system

  • Promising Results In First Blinded Study Of Venous Insuffici

  • CCSVI concerns

  • Still anxiously awaiting my MS diagnosis!

  • Appointment in Poland!

  • Iron metabolism panels should be a first

  • Manitoba: Facebook Group

  • Common Symptoms

  • Avonex or Copaxone? i need to pick one today......

  • Marc (Wheelchair Kamikaze) is "going for it"

  • After Kidney Transplant & CCSVI Treatment Same Symptoms

  • CCSVI -- why we need more research

  • MS Interferon Drugs -- Brain Atrophy and Other Problems

  • Avonex, Betaferon or Rebif?

  • Thalassemia Major, Anyone?

  • Hemochromatosis Anyone?

  • Thalassemia minor, anyone? Or Anemia?

  • BIG ON CCSVI, Dr Tom Gilhooly talks about CCSVI and the LDN

  • Spotlight on Alemtuzumab

  • Situation in Italy...your views?

  • Tβ4 Significantly Improves Functional Recovery

  • Primary Progressive and accidents

  • Hot head

  • Buffalo CCSVI testing "On Hold"

  • Terry Wahls and using a neuromusular Aide: The 300 PV EMP

  • How to contact Dr. Simka?

  • Insurance question for USA residence

  • Hello ,, new here

  • CCSVI in Italain Parliament :)

  • Stars are all coming out for Tiger

  • MS Society Launches Major Manifesto Campaign, UK

  • CCSVI "Success" Stories

  • False Creek

  • My MRV image from False Creek

  • Researchers find further evidence linking Epstein-Barr virus

  • Got call from Albany yesterday

  • Updates on Stanford trial?

  • Interesting question..

  • We are all the same...

  • Seeking advice...

  • Appt with Dr Kostecki

  • CBC announcement

  • Dr. Zamboni words of caution on stents.

  • TRANSLATION ANYONE???????

  • just an interesting view

  • 2nd European LDN Conference 24th of April, 2010

  • The results of Dr. Simka

  • Calcium EAP

  • venography etc

  • Slowed perfusion in the MS brain- new paper by Dr. Simka

  • Vascular headche/pain in eye??

  • From the perspective of a fourteen year old

  • Anti-depressants, bladder incontinence and CCSVI

  • anyone know the difference?

  • Is this a silly question?

  • Whic are the main problems found

  • HIV, HHV,... stenosis ?

  • My MRV pics -- please see and help!

  • California PCB OIL LAWSUIT

  • PCB FISH OIL

  • if ms causes ccsvi liberation wouldnt work

  • MS society in canada bought : CCSVI.CA

  • Help with TIMS

  • New Stem Cell Findings Could Lead To Neural Disorders Cures

  • Excellent study of Vascular vs. Autoimmune theory, from 80's

  • Rubber is about to hit the road in the UK

  • a little update on my condition/diagnosis

  • mssociety feedback

  • Whats all this about?

  • What's the problem? and what I did about it

  • UK to Poland payment ???

  • LDN Phase II Trial Results Published

  • IBT diary - Asia

  • This one's for Jimmylegs, Mag and memory

  • NEW FOR GUYS FROM UK

  • My liberation process (right IJV) in Mumbai, India

  • Update on Manoj, our India Pioneer Stentee!

  • The dangers of false hope ?

  • Stem Cell therapy in Mexico

  • Hello

  • CCSVI march on parliament hill in Ottawa

  • Stents in Neck as Good as Surgery to Prevent Stroke

  • Iron deposits in brain lead to memory impairment

  • MSRC Chatroom Sessions for Week commencing 1st March

  • Poland in May!

  • Well - i think i have MS

  • Surrendering

  • From Ireland to Frankfurt for CCSVI : local information need

  • NEWS

  • Help travelling from Ireland to Frankfurt: local info needed

  • cerebrospinal fluid dynamics (news from Zamboni)

  • Link to lots of Italian CCSVI testimonies..

  • APRIL Poland anyone??

  • First Operation in Frankfurt!!!!!!!!! WOW :)

  • Severity of CCSVI in patients with MS assessed

  • ctv links

  • Regular Exercise Reduces Patient Anxiety by 20 Percent, Stud

  • Dr. Zamboni : PLEASE HEAR ME!!!!

  • Back From Vancouver...I'd wait if I were you

  • Stents for carotid arteries

  • Steriods side effects

  • i.b.t update

  • My strange unexplainable liberation procedure

  • Tims Members Questions for Dr. Dake

  • New to TIMS

  • CCSVI Treatment Reports


    • This Is MS » General FAQs:

  • What does "ThisIsMS" mean?: Eh, it is a take off on "This is Spinal Tap." MS is not a death sentence, so we wanted to avoid such heavy-handed names like 'mshope' or 'beatms.' Plus, it is pretty easy to spell, and hopefully, to remember! But admittedly, pretty difficult for those of us suffering from dyslexia-- Sorry!

  • I read in a news article that someone 'died from complications of MS.' What does that mean?: MS is not a fatal disease. In general, what is meant is the following:

    Secondary symptoms of MS are complications that can arise as a result of the primary symptoms. For example, bladder dysfunction can cause repeated urinary tract infections. Inactivity can result in loss of muscle tone and disuse weakness (not related to demyelination), poor postural alignment and trunk control, decreased bone density (and resulting increased risk of fracture), and shallow, inefficient breathing. Immobility can lead to pressure sores. While secondary symptoms can be treated, the optimal goal is to avoid them by treating the primary symptoms (Source: National Multiple Sclerosis Society). These secondary systems can make other, more dangerous problems likely e.g., falling.


  • Who runs this site?: We are a group of friends who have been affected by MS in various ways--some are generally interested in autoimmune diseases, some have it, some have significant others who have it, others still have best friends or parents. All of us are disgusted with the state of treatments today and at the same time, brimming with excitement over what is being done in the research and drug pipeline field.

    We are taking a stance of anonymity for a reason-- this site is to remain unbiased and focused on MS, not us. We contribute by using our skills to create a community and fill it with content, the rest is up to our users such as yourself.



    • This Is MS » Latest 20 pages from Content:

  • Informational Resources on Tysabri as a Treatment for Multiple Sclerosis: -

  • The Blood Brain Barrier is the Problem: Macrophages Penetrate BBB to cause trouble; Ideas on how to stop them -

  • LDN & the National Multiple Sclerosis Society: Anti-LDN article debunked -

  • United States Patent for the use of LDN in Treating Multiple Sclerosis: Filed by Dr. Bernard Bihari -


    • Page Generation: 0.23 Seconds
    Site Map ©